|
TMPPE expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.594199999992E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.951300E-04 |
| Normal-vs-Stage2 |
6.384400E-03 |
| Normal-vs-Stage3 |
3.64929999999708E-05 |
| Normal-vs-Stage4 |
3.594500E-04 |
| Stage1-vs-Stage2 |
9.421800E-01 |
| Stage1-vs-Stage3 |
3.609800E-01 |
| Stage1-vs-Stage4 |
5.375400E-01 |
| Stage2-vs-Stage3 |
4.889200E-01 |
| Stage2-vs-Stage4 |
5.904200E-01 |
| Stage3-vs-Stage4 |
9.454200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.94689999999987E-05 |
| Normal-vs-AfricanAmerican |
8.523800E-02 |
| Normal-vs-Asian |
6.372200E-04 |
| Caucasian-vs-AfricanAmerican |
3.730200E-01 |
| Caucasian-vs-Asian |
7.046000E-01 |
| AfricanAmerican-vs-Asian |
3.002000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.18419999994845E-06 |
| Normal-vs-Female |
3.964800E-04 |
| Male-vs-Female |
4.802200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.195400E-03 |
| Normal-vs-Age(41-60Yrs) |
3.73200000000073E-05 |
| Normal-vs-Age(61-80Yrs) |
1.849410E-04 |
| Normal-vs-Age(81-100Yrs) |
4.258900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.410600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.209000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.383400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.667800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.752400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.037400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.956200E-02 |
| Classical-VS-Follicular |
1.340530E-03 |
| Classical-VS-Other |
5.447500E-02 |
| Classical-VS-Normal |
2.580800E-03 |
| Tall-VS-Follicular |
3.803400E-01 |
| Tall-VS-Other |
9.378100E-02 |
| Tall-VS-Normal |
2.824200E-04 |
| Follicular-VS-Other |
3.729800E-01 |
| Follicular-VS-Normal |
4.19459999956295E-07 |
| Other-VS-Normal |
8.955800E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.48970000000282E-05 |
| Normal-vs-N1 |
8.43970000000693E-05 |
| N0-vs-N1 |
3.649800E-01 |
|
|
